Fewer Pennsylvanians were hospitalized for opioid overdoses last year than in 2017, according to data released Wednesday, which supports other indications that the public manifestations of the epidemic are on the wane.
Officials this week have been quick to add that even as the state's drug problem brings fewer hospitalizations and deaths, a next wave of designer drugs and stimulants is gathering.
"A tremendous amount of work has been done, both in the private and public sector, to combat this opioid problem," said Joe Martin, executive director of the Pennsylvania Health Care Cost Containment Council, which is releasing the data. "So the supply of [opioids] has been reduced.
"The addiction doesn't go away, so people turn to other things," he added. "That's why, I think, we're seeing increases in cocaine and methamphetamines as people turn to other sources for feeding their addictions."
The council, an independent state agency that collects and analyzes healthcare data, found that hospital admissions for opioid overdose plunged by 24% in 2018 compared to 2017, which had seen a slight rise from the prior year.
The 2,667 hospitalizations for opioid overdose don't include those who only visited emergency rooms, nor those revived by public safety workers or civilians but not taken to a hospital.
Read More
Last year, opioid overdose hospitalizations per 100,000 residents were highest in Philadelphia (44.8), Lawrence (41.6), Fayette (40), Carbon (36.9) and Venango (34.8) counties, according to the council. Allegheny County's rate was 22.9 opioid overdose hospital admissions per 100,000 residents, down from 41.2 in 2017 and slightly lower than the statewide rate of 25.1.
Medics, too, are slightly less swamped after years spent running from overdose to overdose.
In Allegheny County, 911 calls for suspected overdoses dropped by 24% last year versus 2017, according to tallies released last week in response to a Pittsburgh Post-Gazette query. That drop included a 30% plunge in the city, which typically accounts for nearly half of county OD calls.
Observers believe that the widespread availability of naloxone, which reverses opioid overdoses, has led to more “saves” by civilians, many of which are never reported.

Overdose survivors who do get to the hospital may be benefiting from new tactics aimed at encouraging recovery.
UPMC's emergency departments are starting overdose patients on buprenorphine — frequently referred to by the brand name Suboxone — said Michael Lynch, medical director of the Pittsburgh Poison Center, at a Monday event called Opioids: The Fight Continues, at the UPMC Hillman Cancer Center Pavilion. That relatively mild opioid eliminates the craving for heroin.
Initial results, he said, indicate that "70% of our patients who we started with buprenorphine were in treatment in 30 days" versus just 32% of patients not started on buprenorphine.
He said the region's largest hospital system has also embraced the "warm handoff" philosophy, in which opioid overdose survivors are steered straight from emergency rooms to treatment programs. "Across the system we've engaged thousands of patients with a roughly 50 percent engagement rate," he said, meaning that half are entering treatment programs.
Comparing 2018 to 2016, hospitalizations for opioid overdoses were down 20% statewide, according to the council data. But overdose admissions related to cocaine were up 27% (to a 2018 total of 949) and admissions for amphetamines up 66% (to 314).
Mr. Martin said the geography of the cocaine and meth surge hasn't yet been analyzed, but expected that "we're going to see more of it in areas that are disadvantaged economically, and where you have lower income levels."
The cost of the opioid binge remains high.
Over three years, the opioid overdose admissions amounted to 37,977 days of hospital stays, and roughly three-fourths of the admissions were paid for through government programs, according to the council's data. Roughly 9% of people admitted for heroin overdoses died, as did 5% of those who took too many prescription opioids.
Southwestern Pennsylvania drug deaths dropped 40% last year, from the record toll of 1,427 in 2017. Officials agreed that the addiction problem as a whole shows little sign of fading away, and may just be taking different forms, which entail new risks.
"The black market is filled with little blue pills that are made from fentanyl," said state Secretary of Health Rachel Levine, at the UPMC event. People who think they are buying a prescription pill on the black market may instead get something far more potent, she warned.
Drug Enforcement Administration intelligence specialist Brian Dempsey, speaking at the same event, said that this year the DEA's Pittsburgh unit has seen "four people try to order pill presses so they can press their own pills" from illegal drugs.
The DEA is also seeing new substances from new sources, like the designer drug flualprazolam flowing from Poland. Pittsburgh's heroin purity level, meanwhile, remains among the highest of any city in the nation.
Dr. Levine said that while measures put in place since 2016 have pushed down the prescribing of opioids statewide, the narcotic medicines are appropriate for cancer and end-of-life pain, and after surgery.
"You can't cut off patients” who have been on painkillers long-term, she added, because that could drive them to illicit drugs. She said that medical marijuana is a valid alternative to opioids for severe chronic pain.
Rich Lord: rlord@post-gazette.com or 412-263-1542. Shelly Bradbury contributed.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.